Document
Academic Article
RDF description of Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial - http://irises.unisr.it/resource/item/155386
Generically Dependent Continuant
Article
Information Content Entity
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial